The analysis of in vitro transforming growth factor-β1 (TGF-β1) production by peripheral blood in overt and pre-clinical type 1 diabetes mellitus

This publication has 15 references indexed in Scilit:

• Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-β1 and type IV collagen in diabetic vasculopathy
  Journal Of Hypertension, 1998
• Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers
  Diabetes, 1997
• Transforming Growth Factor β (TGF-β)-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self–Major Histocompatibility Complex (MHC) Class II–specific, Regulatory CD4+ T Cell Lines
  The Journal of Experimental Medicine, 1997
• Interactions of Age, Islet Cell Antibodies, Insulin Autoantibodies, and First-Phase Insulin Response in Predicting Risk of Progression to IDDM in ICA+ Relatives: The ICARUS Data Set
  Diabetes, 1996
• Cytokine inhibitors in autoimmune disease
  Seminars in Arthritis and Rheumatism, 1996
• Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture
  European Journal of Immunology, 1996
• Central Role of TGF-β in the Pathogenesis of Diabetic Nephropathy and Macrovascular Complications: A Hypothesis
  Diabetic Medicine, 1996
• Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
  Growth Factors, 1993
• Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
  Proceedings of the National Academy of Sciences, 1991
• Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
  Arthritis & Rheumatism, 1990